Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S James

Showing results (1-10 of 333) with videos related to

Pageof 34
Sort By:
AIDS Treatment News|September 26, 2001
Syringe prescription study unexpected bonus: helping long-time users quit drugsJ S James
AIDS Treatment News|September 26, 2001
Tenofovir: FDA hearing October 3, public comment deadlines September 26J S James
AIDS Treatment News|September 26, 2001
AIDS treatment activists form new coalitionJ S James
AIDS Treatment News|February 17, 1995
Valacyclovir study stopped -- worse survivalJ S James
AIDS Treatment News|May 5, 1995
Agouron protease inhibitor AG1343: activity reportedJ S James
AIDS Treatment News|July 21, 1995
AIDS research "spin-off"--ganciclovir CMV prevention after liver transplantationJ S James
AIDS Treatment News|September 1, 1995
Hydroxyrea and ddI: French study publishedJ S James
AIDS Treatment News|September 1, 1995
Thalidomide: new expanded access for wastingJ S James
AIDS Treatment News|September 29, 1995
ICAAC 1995: new perspectives on treatmentJ S James
AIDS Treatment News|September 29, 1995
Symptom-reduction trials at FDA clinical trials workshop. Food and Drug AdministrationJ S James
Pageof 34

Showing results (1-10 of 333) with videos related to

Sort By:
Pageof 34
AIDS Treatment News|September 26, 2001
Syringe prescription study unexpected bonus: helping long-time users quit drugsJ S James
AIDS Treatment News|September 26, 2001
Tenofovir: FDA hearing October 3, public comment deadlines September 26J S James
AIDS Treatment News|September 26, 2001
AIDS treatment activists form new coalitionJ S James
AIDS Treatment News|February 17, 1995
Valacyclovir study stopped -- worse survivalJ S James
AIDS Treatment News|May 5, 1995
Agouron protease inhibitor AG1343: activity reportedJ S James
AIDS Treatment News|July 21, 1995
AIDS research "spin-off"--ganciclovir CMV prevention after liver transplantationJ S James
AIDS Treatment News|September 1, 1995
Hydroxyrea and ddI: French study publishedJ S James
AIDS Treatment News|September 1, 1995
Thalidomide: new expanded access for wastingJ S James
AIDS Treatment News|September 29, 1995
ICAAC 1995: new perspectives on treatmentJ S James
AIDS Treatment News|September 29, 1995
Symptom-reduction trials at FDA clinical trials workshop. Food and Drug AdministrationJ S James
Pageof 34